Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985-1998).
Overtly healthy Doberman pinschers, having moderate to severe myocardial failure secondary to dilated cardiomyopathy, which experienced ventricular tachycardia, syncope or collapse, and sudden death were studied to determine the effect of antiarrhythmic medication on their clinical outcome. Antiarrhythmia drug therapy may have retarded sudden death in 13 treated dogs compared to the six dogs not administered antiarrhythmia drugs.
Calvert
Clay A
CA
Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.
Brown
John
J
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001947:Breeding; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control / Q000662:veterinary*; D004283:Dog Diseases / Q000188:drug therapy* / Q000401:mortality; D004285:Dogs; D004452:Echocardiography / Q000662:veterinary; D015716:Electrocardiography, Ambulatory / Q000662:veterinary; D005260:Female; D008297:Male; D012189:Retrospective Studies; D016019:Survival Analysis; D013575:Syncope / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*
D000889:Anti-Arrhythmia Agents